Henry Ford Hospital Medical Journal


Early diagnosis and accurate, biologically meaningful classification of prostate neoplasia remain important goals. The relation of evolving clinicopathologic concepts of histologic appearances to potential tumor progression is a major advance in classification of prostatic neoplasia. The criteria for recognizing incidental or "occult" stage A-l adenocarcinomas remain problematic in diagnosis, and focal neoplasms with little or no propensity to progression must be differentiated from cancers with a high likelihood of aggressive behavior. Current histologic grading systems in classifying prostate adenocarcinoma accurately identify two cancer subsets: 1) focal well differentiated tumors which rarely progress, and 2) diffuse poorly differentiated tumors which invariably develop metastatic disease. Unfortunately, the majority of prostatic cancers are classified in the intermediate group in which the prognosis is variable and difficult to differentiate purely by histology. Our laboratory recently adapted image analysis of cellular DNA quantitation—a major improvement in accurately predicting tumor behavior, especially in the intermediate histologic grades. We and others have found that tumors with abnormal (aneuploid) DNA content are more likely to progress than neoplasms with normal (diploid) DNA content.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.